Latest News about psilocybin
Recent news which mentions psilocybin
These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details
November 16, 2022
Tickers
MSSTF
From Benzinga
From Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
From Benzinga
Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University
October 18, 2022
Tickers
SILO
From Benzinga
Studying The 'Magic' In Shrooms: New Research Will Assess Origin Of Psychedelic Properties
October 17, 2022
From Benzinga
Yeast Produces Bread And Psilocybin, This Company Is Moving Into Clinical Trial Phase
October 11, 2022
Tickers
PSYBF
From Benzinga
New Study Looks At Psychedelics And Near-Death Experiences: How They Influence Pespectives On Life And Death
October 07, 2022
From Benzinga
EXCLUSIVE: Global Psychedelics Company Silo Wellness Acquires Dyscovry Science, Including Access To Its Gov Collaborations
September 27, 2022
Tickers
SILFF
From Benzinga
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
September 26, 2022
Tickers
TRYPF
From Benzinga
The Psychedelic Mushroom Edibles Market Proliferates Underground: Here's Why
September 25, 2022
From Benzinga
Psychedelic Science Feature: Psilocybin For Headaches
September 23, 2022
From Benzinga
Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial
September 21, 2022
From Benzinga
This Ecotourism Resort In Jamaica Now Offers Psilocybin Microdosing Retreats And Experiences
September 21, 2022
Tickers
SILFF
From Benzinga
Australia Update: Victoria Officials Seek To Ban Federal Psychedelic Medicine Permits
September 08, 2022
Tickers
MDMA
From Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
September 07, 2022
Tickers
MSSTF
From Benzinga
Two States Discuss Psychedelics Therapy For Veterans With Depression & PTSD In Policy Committees
September 02, 2022
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
From Benzinga
What Psychiatrists Think Of Current US Psychedelics Policies
August 26, 2022
From Benzinga
Promising Finding For Alcohol Addiction: A Solution Just Might Be In Magic Mushrooms
August 25, 2022
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
From Benzinga
Reps. Ocasio-Cortez, Crenshaw, Moulton & Tlaib's Psychedelics & Cannabis Research Amendments Approved As Part Of Defense Bill
July 13, 2022
From Benzinga
As The Conversation Around The Decriminalization Of Psilocybin Increases, What Can We Learn From The Cannabis Industry?
July 11, 2022
From Benzinga
Canadian Senator Uses This Unconventional Method To Fight Depression, And Meet His Wife While You're Here
May 23, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.